Ocuphire Pharma, Inc. Annual Depreciation in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Ocuphire Pharma, Inc. quarterly/annual Depreciation history and growth rate from 2011 to 2023.
  • Ocuphire Pharma, Inc. Depreciation for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
  • Ocuphire Pharma, Inc. Depreciation for the twelve months ending June 30, 2024 was $4K, unchanged year-over-year.
  • Ocuphire Pharma, Inc. annual Depreciation for 2023 was $6K, a 50% increase from 2022.
  • Ocuphire Pharma, Inc. annual Depreciation for 2022 was $4K, unchanged from 2021.
  • Ocuphire Pharma, Inc. annual Depreciation for 2021 was $4K, a 50% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6K +$2K +50% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-08
2022 $4K $0 0% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 $4K -$4K -50% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $8K +$5K +167% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $3K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2014 $28.3K -$8.81K -23.7% Jan 1, 2014 Dec 31, 2014 10-K 2015-03-16
2013 $37.1K -$5.25K -12.4% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-16
2012 $42.4K -$2.68K -5.96% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-21
2011 $45.1K Jan 1, 2011 Dec 31, 2011 10-K 2013-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.